Delivery of small interfering RNA (siRNA) for silencing of aberrantly expressed genes is a promising therapy for the treatment of various genetic disorders. Polymeric carriers have been used in the design of efficient delivery systems to generate nanoscale siRNA polyplexes. Despite the great amount of research pursued on siRNA therapeutics, the underlying mechanisms of polyplex dissociation in cytosol are still unclear. The fate of siRNA polyplexes during intracellular stages of delivery and how the endogenous molecules may affect the integrity of polyplexes remains to be explored. In this study, we have focused on miRNA-21 as a representative anionic endogenous molecule and performed gel electrophoresis mobility shift assays, particle size...
Success of synthetic interfering nucleic acids (siRNAs)-based therapy relies almost exclusively on e...
RNA interference (RNAi) is a promising strategy to inhibit the expression of pathologically relevant...
The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of...
Clinical translation of small interfering RNA (siRNA) nanocarriers is hindered by limited knowledge ...
siRNA and microRNA are promising therapeutic agents, which are engaged in a natural mechanism called...
Polycationic nanocarriers attract increasing attention to the field of siRNA delivery. We investigat...
The development of pharmaceutical technology has enabled the treatment of diseases that were once co...
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, Universidade de Lisboa, Faculdade de F...
peer reviewedPolyplexes are nanoparticles composed of small-interfering RNA (siRNA) and natural or s...
Small interfering RNAs (siRNAs) have recently emerged as a new class of biopharmaceuticals for the t...
The translation of siRNA into clinical therapies has been significantly delayed by issues surroundin...
Despite effective gene silencing in vitro, in vivo delivery and transfection of siRNA remain challen...
It has been two decades since cationic polymers were introduced to the world of oligonucleotides del...
RNA interference (RNAi) is a method that can be used to treat various medical conditions. This metho...
In this study, we formulated polyplexes with different compositions for codelivery of DNA and small-...
Success of synthetic interfering nucleic acids (siRNAs)-based therapy relies almost exclusively on e...
RNA interference (RNAi) is a promising strategy to inhibit the expression of pathologically relevant...
The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of...
Clinical translation of small interfering RNA (siRNA) nanocarriers is hindered by limited knowledge ...
siRNA and microRNA are promising therapeutic agents, which are engaged in a natural mechanism called...
Polycationic nanocarriers attract increasing attention to the field of siRNA delivery. We investigat...
The development of pharmaceutical technology has enabled the treatment of diseases that were once co...
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, Universidade de Lisboa, Faculdade de F...
peer reviewedPolyplexes are nanoparticles composed of small-interfering RNA (siRNA) and natural or s...
Small interfering RNAs (siRNAs) have recently emerged as a new class of biopharmaceuticals for the t...
The translation of siRNA into clinical therapies has been significantly delayed by issues surroundin...
Despite effective gene silencing in vitro, in vivo delivery and transfection of siRNA remain challen...
It has been two decades since cationic polymers were introduced to the world of oligonucleotides del...
RNA interference (RNAi) is a method that can be used to treat various medical conditions. This metho...
In this study, we formulated polyplexes with different compositions for codelivery of DNA and small-...
Success of synthetic interfering nucleic acids (siRNAs)-based therapy relies almost exclusively on e...
RNA interference (RNAi) is a promising strategy to inhibit the expression of pathologically relevant...
The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of...